Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Amen, Daniel G.a; * | Egan, Sachitb | Meysami, Somayehc | Raji, Cyrus A.d | George, Noblee
Affiliations: [a] Amen Clinics, Inc., Costa Mesa, CA, USA | [b] Google Inc., Mountain View, CA, USA | [c] UCLA Medical Center, Los Angeles, CA, USA | [d] UCSF Medical Center, San Francisco, CA, USA | [e] Johns Hopkins University, Baltimore, MD, USA
Correspondence: [*] Correspondence to: Daniel G. Amen, MD, Amen Clinics, Inc., 3150 Bristol Street #400, Costa Mesa, CA 92626, USA. E-mail: daniel@amenclinics.com.
Abstract: Background:Understanding the influence of aging on the brain remains a challenge in determining its role as a risk factor for Alzheimer’s disease. Objective:To identify patterns of aging in a large neuroimaging cohort. Methods:A large psychiatric cohort of 31,227 individuals received brain SPECT at rest and during a concentration task for a total of 62,454 scans. ANOVA was done to identify the mean age trends over the course of the age range in this group, 0–105 years. A regression model in which brain SPECT regions of interest was used to predict chronological age (CA) was then utilized to derive brain estimated age (BEA). The difference between CA and BEA was calculated to determine increased brain aging in common disorders in our sample such as depression, dementia, substance use, and anxiety. Results:Throughout the lifespan, variations in perfusion were observed in childhood, adolescence, and late life. Increased brain aging was seen in alcohol use, cannabis use, anxiety, bipolar, schizophrenia, attention-deficit/hyperactivity disorder, and in men. Conclusion:Brain SPECT can predict chronological age and this feature varies as a function of common psychiatric disorders.
Keywords: Aging, alcohol use, attention-deficit/hyperactivity disorder, bipolar, brain SPECT, cannabis use, schizophrenia
DOI: 10.3233/JAD-180598
Journal: Journal of Alzheimer's Disease, vol. 65, no. 4, pp. 1087-1092, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl